These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22306368)

  • 41. Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer.
    Grando JP; Kuasne H; Losi-Guembarovski R; Sant'ana Rodrigues I; Matsuda HM; Fuganti PE; Gregório EP; Júnior FL; de Menezes RP; de Freitas Rodrigues MA; de Syllos Cólus IM
    Clin Exp Med; 2009 Mar; 9(1):21-8. PubMed ID: 18979064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
    Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
    Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
    Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer.
    Ma QW; Lin GF; Chen JG; Shen JH
    Biomed Environ Sci; 2002 Sep; 15(3):253-60. PubMed ID: 12500666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta, Vietnam.
    Agusa T; Iwata H; Fujihara J; Kunito T; Takeshita H; Minh TB; Trang PT; Viet PH; Tanabe S
    Toxicol Appl Pharmacol; 2010 Feb; 242(3):352-62. PubMed ID: 19914269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
    Karagas MR; Tosteson TD; Morris JS; Demidenko E; Mott LA; Heaney J; Schned A
    Cancer Causes Control; 2004 Jun; 15(5):465-72. PubMed ID: 15286466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer.
    Lin YC; Chen WJ; Huang CY; Shiue HS; Su CT; Ao PL; Pu YS; Hsueh YM
    Toxicol Sci; 2018 Jul; 164(1):328-338. PubMed ID: 29669044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene environment interaction in urinary bladder cancer with special reference to organochlorine pesticide: a case control study.
    Sharma T; Jain S; Verma A; Sharma N; Gupta S; Arora VK; Dev Banerjee B
    Cancer Biomark; 2013; 13(4):243-51. PubMed ID: 24240585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
    Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
    Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir Valley.
    Malik MA; Upadhyay R; Mittal RD; Zargar SA; Modi DR; Mittal B
    J Gastrointest Cancer; 2009; 40(1-2):26-32. PubMed ID: 19521675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GSTM1 and APE1 genotypes affect arsenic-induced oxidative stress: a repeated measures study.
    Breton CV; Kile ML; Catalano PJ; Hoffman E; Quamruzzaman Q; Rahman M; Mahiuddin G; Christiani DC
    Environ Health; 2007 Dec; 6():39. PubMed ID: 18053222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study.
    Karagas MR; Park S; Nelson HH; Andrew AS; Mott L; Schned A; Kelsey KT
    Int J Hyg Environ Health; 2005; 208(5):321-7. PubMed ID: 16217917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.
    Seow WJ; Pan WC; Kile ML; Tong L; Baccarelli AA; Quamruzzaman Q; Rahman M; Mostofa G; Rakibuz-Zaman M; Kibriya M; Ahsan H; Lin X; Christiani DC
    Cancer; 2015 Jul; 121(13):2222-9. PubMed ID: 25759212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
    Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions.
    Valenzuela OL; Drobná Z; Hernández-Castellanos E; Sánchez-Peña LC; García-Vargas GG; Borja-Aburto VH; Stýblo M; Del Razo LM
    Toxicol Appl Pharmacol; 2009 Sep; 239(2):200-7. PubMed ID: 19538983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between GSTO2 polymorphism and the urinary arsenic profile in copper industry workers.
    Paiva L; Hernández A; Martínez V; Creus A; Quinteros D; Marcos R
    Environ Res; 2010 Jul; 110(5):463-8. PubMed ID: 20045512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.
    Yu C; Hequn C; Longfei L; Long W; Zhi C; Feng Z; Jinbo C; Chao L; Xiongbing Z
    Oncotarget; 2017 Jan; 8(2):3246-3258. PubMed ID: 27911277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.